< Back to previous page
SBO COMPLEXYS.COM: Nanobodies as allosteric modulators of transient protein complexes to innovate therapy and drug discovery (FWOSBO19)
This SBO project with the ultimate goal of establishing a spin-off company, aims to introduce nano bodies as allostered modulators of transient protein complexes to innovate therapy and drug development. Committed to launching Complexys.com in 2021, we prefer to work on specifically selected protein complexes to prove our concept and validate our drug discovery platform.
Date:1 Jul 2017 → 31 Dec 2019
Disciplines:Medical biochemistry and metabolism not elsewhere classified, Nanobiotechnology